Study of APR-1051 in Patients With Advanced Solid Tumors

Clinical trial NCT06260514 · RECRUITING

Trial details

NCT number: NCT06260514
Sponsor: Aprea Therapeutics
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumor

Start date: 2024-06-13
Primary completion: 2027-06-01
Enrollment: 90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.